Drugmakers are teaming up like never before to fight the coronavirus. The benefits could last well beyond the pandemic.
“Nearly 200 in development. Thirty-nine in human clinical trials. Nine in Phase III trials. I mean, yes, that is something.” There is marvel in Seth Berkley’s voice as he relates the progress made so far in producing a possible vaccine against COVID-19. But then, he’s quick to point out that these numbers are more mile markers than milestones. “We don’t know whether any of those are going to make it through,” he says. There remains much testing to be done before we’ll know if any of these valiant efforts produces a safe and truly effective countermeasure to this pandemic.